Literature DB >> 33254974

In situ differentiation of human-induced pluripotent stem cells into functional cardiomyocytes on a coaxial PCL-gelatin nanofibrous scaffold.

Divya Sridharan1, Arunkumar Palaniappan2, Britani N Blackstone3, Julie A Dougherty4, Naresh Kumar5, Polani B Seshagiri6, Nazish Sayed7, Heather M Powell8, Mahmood Khan9.   

Abstract

Human-induced pluripotent stem cells (hiPSCs) derived cardiomyocytes (hiPSC-CMs) have been explored for cardiac regeneration and repair as well as for the development of in vitro 3D cardiac tissue models. Existing protocols for cardiac differentiation of hiPSCs utilize a 2D culture system. However, the efficiency of hiPSC differentiation to cardiomyocytes in 3D culture systems has not been extensively explored. In the present study, we investigated the efficiency of cardiac differentiation of hiPSCs to functional cardiomyocytes on 3D nanofibrous scaffolds. Coaxial polycaprolactone (PCL)-gelatin fibrous scaffolds were fabricated by electrospinning and characterized using scanning electron microscopy (SEM) and fourier transform infrared (FTIR) spectroscopy. hiPSCs were cultured and differentiated into functional cardiomyocytes on the nanofibrous scaffold and compared with 2D cultures. To assess the relative efficiencies of both the systems, SEM, immunofluorescence staining and gene expression analyses were performed. Contractions of differentiated cardiomyocytes were observed in 2D cultures after 2 weeks and in 3D cultures after 4 weeks. SEM analysis showed no significant differences in the morphology of cells differentiated on 2D versus 3D cultures. However, gene expression data showed significantly increased expression of cardiac progenitor genes (ISL-1, SIRPA) in 3D cultures and cardiomyocytes markers (TNNT, MHC6) in 2D cultures. In contrast, immunofluorescence staining showed no substantial differences in the expression of NKX-2.5 and α-sarcomeric actinin. Furthermore, uniform migration and distribution of the in situ differentiated cardiomyocytes was observed in the 3D fibrous scaffold. Overall, our study demonstrates that coaxial PCL-gelatin nanofibrous scaffolds can be used as a 3D culture platform for efficient differentiation of hiPSCs to functional cardiomyocytes.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiomyocytes; Gelatin; Induced pluripotent stem cells; Nanofibrous scaffolds; Polycaprolactone; Stem cell differentiation

Mesh:

Substances:

Year:  2020        PMID: 33254974      PMCID: PMC7708677          DOI: 10.1016/j.msec.2020.111354

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  54 in total

1.  Regulation of electrospun scaffold stiffness via coaxial core diameter.

Authors:  J W Drexler; H M Powell
Journal:  Acta Biomater       Date:  2010-10-25       Impact factor: 8.947

Review 2.  Effect of substrate mechanics on cardiomyocyte maturation and growth.

Authors:  Marwa Tallawi; Ranjana Rai; Aldo R Boccaccini; Katerina E Aifantis
Journal:  Tissue Eng Part B Rev       Date:  2014-11-12       Impact factor: 6.389

Review 3.  Induced pluripotent stem cells as a disease modeling and drug screening platform.

Authors:  Antje D Ebert; Ping Liang; Joseph C Wu
Journal:  J Cardiovasc Pharmacol       Date:  2012-10       Impact factor: 3.105

Review 4.  Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine.

Authors:  Nazish Sayed; Chun Liu; Joseph C Wu
Journal:  J Am Coll Cardiol       Date:  2016-05-10       Impact factor: 24.094

5.  The effect of 3D nanofibrous scaffolds on the chondrogenesis of induced pluripotent stem cells and their application in restoration of cartilage defects.

Authors:  Ji Liu; Huarong Nie; Zhengliang Xu; Xin Niu; Shangchun Guo; Junhui Yin; Fei Guo; Gang Li; Yang Wang; Changqing Zhang
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

Review 6.  Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell Promise.

Authors:  Robin Duelen; Maurilio Sampaolesi
Journal:  EBioMedicine       Date:  2017-01-27       Impact factor: 8.143

7.  Development of a Human iPSC Cardiomyocyte-Based Scoring System for Cardiac Hazard Identification in Early Drug Safety De-risking.

Authors:  Ivan Kopljar; Hua Rong Lu; Karel Van Ammel; Martin Otava; Fetene Tekle; Ard Teisman; David J Gallacher
Journal:  Stem Cell Reports       Date:  2018-12-11       Impact factor: 7.765

8.  Assessment of temporal functional changes and miRNA profiling of human iPSC-derived cardiomyocytes.

Authors:  Naresh Kumar; Julie A Dougherty; Heather R Manring; Ibrahim Elmadbouh; Muhamad Mergaye; Andras Czirok; Dona Greta Isai; Andriy E Belevych; Lianbo Yu; Paul M L Janssen; Paolo Fadda; Sandor Gyorke; Maegen A Ackermann; Mark G Angelos; Mahmood Khan
Journal:  Sci Rep       Date:  2019-09-12       Impact factor: 4.379

Review 9.  3D Cardiac Cell Culture: A Critical Review of Current Technologies and Applications.

Authors:  Christian Zuppinger
Journal:  Front Cardiovasc Med       Date:  2019-06-26

Review 10.  Human iPSC banking: barriers and opportunities.

Authors:  Ching-Ying Huang; Chun-Lin Liu; Chien-Yu Ting; Yueh-Ting Chiu; Yu-Che Cheng; Martin W Nicholson; Patrick C H Hsieh
Journal:  J Biomed Sci       Date:  2019-10-28       Impact factor: 8.410

View more
  1 in total

Review 1.  Nanotechnology-Driven Cell-Based Therapies in Regenerative Medicine.

Authors:  D Alzate-Correa; W R Lawrence; A Salazar-Puerta; N Higuita-Castro; D Gallego-Perez
Journal:  AAPS J       Date:  2022-03-15       Impact factor: 3.603

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.